Previously a cofounder of Cardea Bio, Ross brings in a decade of entrepreneurial experience in biotechnology.
CRISPR Group Lead, Head of Sales
As the leader of our CRISPR Group, Ken brings in decades of experience in commercializing life sciences.
Vice President of Operations
Holding both a CPA and a CFA, Zack's business savvy helped build the commercial pipeline at Cardea Bio, where he was on the Business Development & Strategy team.
Board of Directors
Dr. Kiana Aran
Board Member, Co-Founder
Dr. Aran is a pioneer of combining CRISPR with modern electronics. In addition to inventing the CRISPR-Chip™, she is an Associate Professor of Medical Diagnostics and Therapeutics at Keck Graduate Institute.
Dr. Paul Grint
Dr. Grint has more than two decades of experience in biologics and small-molecule research and development, including serving on the Boards of Illumina and AmpliPhi Biosciences.
Dr. Toby Richardson
Toby brings to the board strong experience of commercializing life sciences from a machine learning and data analytics perspective. As Co-founder of Denovium and fromer VP at Synthetic Genomics, Toby has strong experience in commercializing life sciences.